Gulou District
Nanjing, Jiangsu, 210029, China
NCT Number: NCT06473220
To explore the effects of narrative nursing on mental state, life ability and emotion of patients with Alzheimer's disease (AD).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Nanjing, Jiangsu, 210029, China
There is no effective clinical treatment, mainly through taking Western drugs to control the Alzheimer's disease, but the treatment cycle is long, the cost of drugs is high, and the patient's family nee care, resulds long-termting in a huge economic and psychological burden on the patient and family recipients. Narrative nursing is an intervention mode of psychological nursing.In practice, narrative nursing can guide patients to actively organize experiences into various events with certain practical significance, attach importance to personal feelings and experiences, promote the psychological growth of patients and promote the generation of upward motivation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Narrative nursing is an intervention mode of psychological nursing.
Time frame: After 1, 2 and 4 weeks after hospitalization
The simple mental state Intelligence Scale (MMSE) was used to evaluate the mental state of the patients before and after the nursing intervention. The scale was mainly composed of 5 dimensions, namely orientation ability, recall ability, memory ability, attention and calculation ability, and language ability, and contained a total of 30 items. The total score was 0-30 points, the higher the score, the better the mental state of the patients.
Time frame: After 1, 2 and 4 weeks after hospitalization
The self-care ability measurement (ESCA) scale was used to evaluate the practical self-care ability of patients in the two groups before and after nursing intervention. The scale was mainly composed of four dimensions: self-concept, health knowledge mastery level, sense of responsibility, and self-care practical skills, and contained 43 items with a total score of 0-172. It shows that the actual ability of self-care is better.
Time frame: After 1, 2 and 4 weeks after hospitalization
The score consisted of 17 items, including self-awareness, work and interest, gastrointestinal symptoms, weight loss, hypochondriasis, sleep difficulty, etc. The total score < 7 was considered normal, 7 to 17 divided into possible depression syndrome, > 17-24 were classified as having depression, and> 24 were classified as major depression.
Time frame: After 1, 2 and 4 weeks after hospitalization
The score includes two dimensions: spirituality and physicality, with a total of 14 items, including gastrointestinal and digestive symptoms, depressive mood, sensory system symptoms, behavioral manifestations when communicating with others, somatic anxiety, cognitive function, etc. The total score is > 28, which is classified as severe anxiety, 21 to 28 grades are anxious, 14 to < 21 is classified as anxiety, 7 to < 14 scores may have anxiety, and <7 is considered normal.
Nanjing Medical University
Other
Evaluation of the Effectiveness of Narrative Nursing in Patients With Alzheimer's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05246332
Alzheimer Disease, Anxiety Disorders
Kaohsiung City, Taiwan
View Trial DetailsNCT05478681
Alzheimer Disease, Anxiety Disorders
Houston, Texas, United States
View Trial DetailsNCT06812442
Alzheimer Disease, Anxiety Disorders
Serpa, Beja District, Portugal
View Trial DetailsNCT02317523
Alzheimer Dementia, Alzheimer Disease
La Jolla, California, United States
View Trial Details